A molecular mechanism for transthyretin amyloidogenesis
A number of disease-causing human transthyretin (TTR) mutations are known to lead to amyloid formation. Here the authors combine neutron crystallography, native mass spectrometry and modelling studies to characterize the T119M and S52P-TTR mutants, providing mechanistic insights into TTR amyloidosis...
Guardado en:
Autores principales: | Ai Woon Yee, Matteo Aldeghi, Matthew P. Blakeley, Andreas Ostermann, Philippe J. Mas, Martine Moulin, Daniele de Sanctis, Matthew W. Bowler, Christoph Mueller-Dieckmann, Edward P. Mitchell, Michael Haertlein, Bert L. de Groot, Elisabetta Boeri Erba, V. Trevor Forsyth |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d3204d9671444e838d043f4321cfd3bb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity
por: Ricardo Sant'Anna, et al.
Publicado: (2016) -
Inhibition of the mechano-enzymatic amyloidogenesis of transthyretin: role of ligand affinity, binding cooperativity and occupancy of the inner channel
por: Guglielmo Verona, et al.
Publicado: (2017) -
Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden
por: J Gustav Smith, et al.
Publicado: (2021) -
Aggregated transthyretin is specifically packaged into placental nano-vesicles in preeclampsia
por: Mancy Tong, et al.
Publicado: (2017) -
Epidemiology of variant transthyretin amyloidosis at a reference center in Argentina
por: Maria S. Saez, et al.
Publicado: (2021)